Filtros de búsqueda

Lista de obras de

5α-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models

artículo científico publicado en 2013

A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancer

artículo científico publicado en 2011

A Paracrine Role for IL6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells

artículo científico publicado en 2015

A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer

artículo científico publicado en 2013

A molecular correlate to the Gleason grading system for prostate adenocarcinoma

artículo científico publicado en 2006

A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy

artículo científico publicado en 2007

A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49

artículo científico publicado en 2002

A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer

artículo científico publicado en 2013

A novel method of generating prostate cancer metastases from orthotopic implants ⬇️

artículo científico publicado el 1 de julio de 2003

A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer

artículo científico publicado en 2019

A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate tumors

artículo científico publicado en 2013

APC/CTNNB1 (?-catenin) pathway alterations in human prostate cancers

article

AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasis

artículo científico publicado en 2014

Absolute quantification by droplet digital PCR versus analog real-time PCR.

artículo científico publicado en 2013

Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer

artículo científico publicado en 2016

Addition of PSMA ADC to enzalutamide therapy significantly improves survival in in vivo model of castration resistant prostate cancer

artículo científico publicado en 2015

Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment

artículo científico publicado en 2006

Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference

artículo científico publicado en 2006

Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference

artículo científico publicado en 2008

Amplification and overexpression of prosaposin in prostate cancer

artículo científico publicado en 2005

Amplification of the 9p13.3 chromosomal region in prostate cancer.

artículo científico publicado en 2016

An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer

artículo científico publicado en 2007

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

artículo científico publicado en 2017

Androgen receptor splice variants determine taxane sensitivity in prostate cancer

artículo científico publicado en 2014

Androgen receptor variants occur frequently in castration resistant prostate cancer metastases

artículo científico publicado en 2011

Application of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progression ⬇️

artículo científico publicado en 2005

Basic mechanisms responsible for osteolytic and osteoblastic bone metastases

artículo científico publicado en 2006

Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer

artículo científico publicado en 2007

Biotin reagents in antibody pretargeting. 6. Synthesis and in vivo evaluation of astatinated and radioiodinated aryl- and nido-carboranyl-biotin derivatives

artículo científico publicado en 2004

Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment

artículo científico publicado en 2010

Bone morphogenetic proteins and prostate cancer: evolving complexities

artículo científico publicado en 2007

C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis

artículo científico publicado en 2008

CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells

artículo científico publicado en 2015

Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling

artículo científico publicado en 2013

Cancer micrometastasis and tumour dormancy

scientific article published on July 2008

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

artículo científico publicado en 2010

Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy

artículo científico publicado en 2015

Characterization of C4-2 prostate cancer bone metastases and their response to castration

artículo científico publicado en 2003

Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts

artículo científico publicado en 2016

Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases

artículo científico publicado en 2013

Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways

artículo científico publicado en 2014

Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer

artículo científico publicado en 2016

Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes

artículo científico publicado en 2014

Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization

artículo científico publicado en 2002

Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia

artículo científico publicado en 2013

Circulating microRNAs as stable blood-based markers for cancer detection

artículo científico publicado en 2008

Circulating tumor cells as a marker of response: implications for determining treatment efficacy and evaluating new agents

artículo científico

Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors.

artículo científico publicado en 2006

Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer

artículo científico publicado en 2009

Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer

artículo científico publicado en 2002

Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes

artículo científico

Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer

artículo científico publicado en 2014

Comprehensive mutational analysis and mRNA isoform quantification of TP63 in normal and neoplastic human prostate cells

artículo científico publicado en 2009

Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells

artículo científico publicado en 2011

Conversion of Prostate Adenocarcinoma to Small Cell Carcinoma-Like by Reprogramming

artículo científico publicado en 2016

Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas

artículo científico publicado en 2015

DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis

artículo científico publicado en 2009

DIAPH3 governs the cellular transition to the amoeboid tumour phenotype

artículo científico publicado en 2012

Defining the region(s) of deletion at 6q16-q22 in human prostate cancer

artículo científico publicado en 2002

Deletion, mutation, and loss of expression of KLF6 in human prostate cancer

artículo científico publicado en 2003

Detection and characterization of circulating and disseminated prostate cancer cells

artículo científico publicado en 2007

Detection and isolation of prostate cancer cells from peripheral blood and bone marrow

artículo científico publicado en 2003

Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum

artículo científico publicado en 2013

Dietary protein restriction inhibits tumor growth in human xenograft models

artículo científico publicado en 2013

Differential expression of IL-17RC isoforms in androgen-dependent and androgen-independent prostate cancers

artículo científico publicado en 2007

Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases

artículo científico

Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence

artículo científico publicado en 2009

Dormancy in solid tumors: implications for prostate cancer

artículo científico

EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent

artículo científico publicado en 2012

Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells

artículo científico publicado en 2010

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy Series

artículo científico publicado en 2013

Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts

artículo científico publicado en 2014

Elevation of cytokine levels in cachectic patients with prostate carcinoma

artículo científico publicado en 2003

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer

artículo científico publicado en 2015

Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases

artículo científico publicado en 2015

Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells

artículo científico publicado en 2002

Establishment and serial passage of cell cultures derived from LuCaP xenografts

artículo científico publicado en 2013

Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer

artículo científico publicado en 2010

Estrogen effects on tubulin expression and taxane mediated cytotoxicity in prostate cancer cells

artículo científico publicado en 2005

Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer

artículo científico publicado en 2020

Evaluation of the branched-chain DNA assay for measurement of RNA in formalin-fixed tissues

artículo científico publicado en 2008

Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers

artículo científico publicado en 2011

Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes

artículo científico publicado en 2011

Expression of androgen receptor coregulators in prostate cancer

artículo científico publicado en 2004

Expression of cancer/testis antigens in prostate cancer is associated with disease progression

artículo científico publicado en 2010

Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients

artículo científico publicado en 2003

Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia

artículo científico publicado en 2003

FOXO1A Is a Candidate for the 13q14 Tumor Suppressor Gene Inhibiting Androgen Receptor Signaling in Prostate Cancer

article

Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer

artículo científico publicado en 2005

GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical Models.

artículo científico publicado en 2016

Genetic aberrations in prostate cancer by microarray analysis

artículo científico publicado en 2006

Genetic alterations and changes in expression of histone demethylases in prostate cancer.

artículo científico publicado en 2010

Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients

artículo científico publicado en 2008

HE3235 inhibits growth of castration-resistant prostate cancer

artículo científico publicado en 2009

HIF induces human embryonic stem cell markers in cancer cells.

artículo científico publicado en 2011

HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk

artículo científico publicado en 2013

Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors

article

High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer

artículo científico publicado en 2015

Histopathological assessment of prostate cancer bone osteoblastic metastases

artículo científico publicado en 2008

Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases

artículo científico publicado en 2007

Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance.

artículo científico publicado en 2011

Human Prostate Cancer Harbors the Stem Cell Properties of Bone Marrow Mesenchymal Stem Cells ⬇️

artículo científico publicado el 25 de febrero de 2011

Human pHyde is not a classical tumor suppressor gene in prostate cancer

artículo científico publicado en 2003

Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression

artículo científico publicado en 2012

Hyperbaric oxygen does not accelerate latent in vivo prostate cancer: implications for the treatment of radiation-induced haemorrhagic cystitis

artículo científico publicado en 2004

In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues

artículo científico publicado en 2008

In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors

artículo científico publicado en 2005

Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis

artículo científico publicado en 2005

Induction of neuronal apoptosis inhibitory protein expression in response to androgen deprivation in prostate cancer

artículo científico publicado en 2009

Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer

artículo científico publicado en 2013

Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bone

artículo científico publicado en 2013

Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiol

artículo científico publicado en 2002

Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes

artículo científico publicado en 2006

Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability

artículo científico publicado en 2010

Insulin‐like growth factor binding protein‐related protein 1 (IGFBP‐rP1/mac 25) is reduced in human prostate cancer and is inversely related to tumor volume and proliferation index in Lucap 23.12 xenografts ⬇️

artículo científico publicado el 1 de julio de 2003

Isolation and characterization of human and mouse WDR19,a novel WD-repeat protein exhibiting androgen-regulated expression in prostate epithelium

artículo científico publicado en 2003

KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer

artículo científico publicado en 2003

LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling

artículo científico publicado en 2011

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer

artículo científico publicado en 2009

Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines

artículo científico publicado en 2004

Lineage relationship of prostate cancer cell types based on gene expression ⬇️

artículo científico publicado en 2011

Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions

artículo científico publicado en 2012

Low dose, alternating electric current inhibits growth of prostate cancer

artículo científico publicado en 2010

LuCaP 35: A new model of prostate cancer progression to androgen independence ⬇️

artículo científico publicado el 1 de junio de 2003

LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.

artículo científico publicado en 2017

Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth

artículo científico publicado en 2008

Metastases of prostate cancer express estrogen receptor-beta

artículo científico publicado en 2004

Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.

artículo científico publicado en 2011

Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer

artículo científico publicado en 2016

MicroRNA expression profiling in prostate cancer

artículo científico publicado en 2007

Microsatellite instability and mismatch repair target gene mutations in cell lines and xenografts of prostate cancer

artículo científico publicado en 2006

Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15.

artículo científico publicado en 2007

Molecular assays for the detection of microRNAs in prostate cancer

artículo científico publicado en 2009

Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral blood

artículo científico publicado en 2010

Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.

artículo científico publicado en 2007

Molecular characterization of prostatic small-cell neuroendocrine carcinoma

artículo científico publicado en 2003

Molecular determinants of resistance to antiandrogen therapy

artículo científico publicado en 2004

Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance

artículo científico publicado en 2010

Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models

artículo científico publicado en 2018

Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer

artículo científico publicado en 2006

Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer

artículo científico publicado en 2004

NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy

artículo científico publicado en 2012

Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells

artículo científico publicado en 2009

Novel biomarkers for prostate cancer including noncoding transcripts

artículo científico publicado en 2009

Osteoblast-derived factors induce an expression signature that identifies prostate cancer metastasis and hormonal progression.

artículo científico publicado en 2009

Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment.

artículo científico publicado en 2010

Osteoprotegerin in prostate cancer bone metastasis

artículo científico publicado en 2005

Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1, -2, and -4) in prostate cancer

scholarly article by Peter C Black et al published 1 May 2007 in The Prostate

Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone

artículo científico publicado en 2003

Plasma Fatty Acids as Surrogate for Prostate Levels.

artículo científico publicado en 2017

Polycomb-independent activity of EZH2 in castration resistant prostate cancer

Prostate cancer cell phenotypes based on AGR2 and CD10 expression

artículo científico publicado en 2013

Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis

artículo científico publicado en 2014

Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment

artículo científico publicado en 2013

Prostate cancer expression of runt‐domain transcription factor Runx2, a key regulator of osteoblast differentiation and function ⬇️

artículo científico publicado el 15 de junio de 2003

Prostate cancer-associated gene expression alterations determined from needle biopsies

artículo científico publicado en 2009

Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.

artículo científico publicado en 2007

Prostate stem cell antigen is overexpressed in prostate cancer metastases

artículo científico publicado en 2005

Prostate-specific membrane antigen directed selective thrombotic infarction of tumors

artículo científico publicado en 2002

Protease-activated receptor 2 signaling upregulates angiogenic growth factors in renal cell carcinoma

artículo científico publicado en 2012

Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis

artículo científico publicado en 2009

RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid

artículo científico publicado en 2008

RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer

artículo científico publicado en 2004

Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models.

artículo científico publicado en 2017

Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination

artículo científico publicado en 2007

Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention

artículo científico publicado en 2011

Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds

artículo científico publicado en 2004

Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer.

artículo científico publicado en 2015

Reduced expression of the androgen receptor by third generation of antisense shows antitumor activity in models of prostate cancer

artículo científico publicado en 2011

Reprogramming of prostate cancer cells--technical challenges

artículo científico publicado en 2015

Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants

artículo científico publicado en 2011

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer

artículo científico publicado en 2015

Screening of genetic and expression alterations of SRC1 gene in prostate cancer

artículo científico publicado en 2006

Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells

artículo científico publicado en 2012

Serum prosaposin levels are increased in patients with advanced prostate cancer

artículo científico publicado en 2011

Single cell transcriptomic analysis of prostate cancer cells

artículo científico publicado en 2013

SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer

artículo científico publicado en 2008

Spheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype

artículo científico publicado en 2014

Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance

artículo científico

Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures

artículo científico publicado en 2016

Streptavidin in antibody pretargeting. 3. Comparison of biotin binding and tissue localization of 1,2-cyclohexanedione and succinic anhydride modified recombinant streptavidin.

artículo científico publicado en 2002

Stromal mesenchyme cell genes of the human prostate and bladder

artículo científico publicado en 2005

Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

scientific article published on 29 February 2016

TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer.

artículo científico publicado en 2013

TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.

artículo científico publicado en 2008

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

artículo científico publicado en 2006

Targeted androgen pathway suppression in localized prostate cancer: a pilot study

artículo científico publicado en 2013

Targeted chemotherapy with cytotoxic bombesin analogue AN-215 inhibits growth of experimental human prostate cancers.

artículo científico publicado en 2006

Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression

artículo científico publicado en 2018

Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer

artículo científico publicado en 2014

Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis

artículo científico publicado en 2006

Telomerase activity in disseminated prostate cancer cells

artículo científico publicado en 2006

The biology and clinical implications of prostate cancer dormancy and metastasis

artículo científico publicado en 2015

The current state of preclinical prostate cancer animal models

artículo científico publicado en 2008

The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer

artículo científico publicado en 2007

The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells

artículo científico publicado en 2010

The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer

artículo científico publicado en 2006

The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers

artículo científico publicado en 2011

The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow

artículo científico publicado en 2014

The role of tumor microenvironment in prostate cancer bone metastasis

artículo científico publicado en 2007

Transforming Growth Factor-{beta}-Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor Inhibition

artículo científico publicado en 2009

Tumor cell dormancy: an NCI workshop report

artículo científico publicado en 2007

Tumor necrosis factor receptor associated factor-4: an adapter protein overexpressed in metastatic prostate cancer is regulated by microRNA-29a

artículo científico publicado en 2013

Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastases

artículo científico publicado en 2013

VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer

artículo científico publicado en 2012

WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence

artículo científico publicado en 2008

Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer

artículo científico publicado en 2003

s-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cells

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda